即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | SBT-101 | 货号 | BCP49363 |
中文名 | SBT-101 | ||
英文名 | SBT-101 | ||
中文别名 | |||
英文别名 | SBT101;SBT 101; | ||
SMILES | |||
化学名称 | |||
分子式 | 分子量 | ||
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | SBT101 is the first AAV-based gene therapy in development designed to compensate for the disease-causing ABCD1 mutation, to increase ABCD1 expression, and reduce very long chain fatty acid (VLCFA) levels specifically for people living with adrenomyeloneuropathy (AMN). |
相关产品推荐
查看更多 >Tags:SBT-101 供应商,SBT-101 购买,SBT-101 生产,SBT-101 批量,SBT-101 供应,SBT-101 订购,SBT-101 采购